16-fluoroestradiol has been researched along with Metastase in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Ahn, SH; Chae, SY; Choi, WJ; Gong, G; Han, S; Jung, KH; Kim, HJ; Kim, J; Kim, JE; Kim, SB; Kim, SY; Ko, BS; Lee, HS; Lee, JB; Lee, JW; Lee, SH; Lee, SJ; Moon, DH; Oh, SJ; Shin, HJ; Son, BH | 1 |
| Buskens, E; de Bock, GH; de Vries, EF; de Vries, EG; Feenstra, T; Glaudemans, AW; Greuter, MJ; Hospers, GA; Koleva-Kolarova, RG; van Kruchten, M; Vermeulen, KM | 1 |
| Ellis, GK; Gralow, JR; Krohn, KA; Kurland, BF; Lawton, TJ; Linden, HM; Link, JM; Livingston, RB; Mankoff, DA; Peterson, LM; Petra, PH; Schubert, EK; Specht, JM | 1 |
| Doerkson, C; Kumar, P; McEwan, AJ; Mercer, J; Tonkin, K | 1 |
| Jonson, SD; Welch, MJ | 1 |
| Brodack, JW; Dehdashti, F; Katzenellenbogen, JA; Lyss, AP; Mathias, CJ; McGuire, AH; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
1 review(s) available for 16-fluoroestradiol and Metastase
| Article | Year |
|---|---|
PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorine Radioisotopes; Humans; Ligands; Neoplasm Metastasis; Norprogesterones; Progestins; Radiopharmaceuticals; Rats; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Tamoxifen; Tomography, Emission-Computed | 1998 |
1 trial(s) available for 16-fluoroestradiol and Metastase
| Article | Year |
|---|---|
Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.
Topics: Automation; Breast Neoplasms; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Estradiol; Female; Fluorine Radioisotopes; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Receptors, Estrogen; Sensitivity and Specificity | 2007 |
4 other study(ies) available for 16-fluoroestradiol and Metastase
| Article | Year |
|---|---|
Diagnostic accuracy and safety of 16α-[
Topics: Biopsy; Breast Neoplasms; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prospective Studies; Receptors, Estrogen; Recurrence; Republic of Korea | 2019 |
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Topics: Biopsy; Breast Neoplasms; Computer Simulation; Diagnostic Imaging; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus | 2011 |
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.
Topics: Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorine Radioisotopes; Humans; Middle Aged; Neoplasm Metastasis; Radioligand Assay; Sensitivity and Specificity; Tomography, Emission-Computed | 1991 |